Patrick K S, Straughn A B, Minhinnett R R, Yeatts S D, Herrin A E, DeVane C L, Malcolm R, Janis G C, Markowitz J S
Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Clin Pharmacol Ther. 2007 Mar;81(3):346-53. doi: 10.1038/sj.clpt.6100082.
This study explores the hypotheses that: (1) ethanol will interact with dl-Methylphenidate (MPH) to enantioselectively elevate plasma d-MPH, and primarily yield l-ethylphenidate as a transesterification metabolite; (2) women will exhibit lower relative bioavailability of MPH than men; and (3) sex-dependent differences in subjective effects will exist. dl-MPH HCl (0.3 mg/kg) was administered orally 30 min before ethanol, 30 min after ethanol (0.6 gm/kg), or without ethanol, in a randomized, normal subject three-way crossover study of 10 men and 10 women. Pharmacokinetic parameters were compared. Subjective effects were recorded using visual analog scales. One subject was a novel poor MPH metabolizer whose data were analyzed separately. Ethanol after or before MPH significantly (P<0.0001) elevated the geometric mean for the maximum d-MPH plasma concentration (C(max) (+/-SD)) from 15.3 (3.37) ng/ml to 21.5 (6.81) and 21.4 (4.86), respectively, and raised the corresponding geometric mean for the area under the concentration-time curve values from 82.9 (21.7) ng ml/h to 105.2 (23.5) and 102.9 (19.2). l-MPH was present in plasma only at 1-3% of the concentration of d-MPH, except in the poor metabolizer where l-MPH exceeded that of d-MPH. The metabolite l-ethylphenidate frequently exceeded 1 ng/ml in plasma, whereas d-ethylphenidate was detected only in low pg/ml concentrations. Women reported a significantly greater stimulant effect than men when questioned "Do you feel any drug effect?" (P<0.05), in spite of lower mean plasma d-MPH area under the response-time curves in women. Ethanol elevates plasma d-MPH C(max) and area under the concentration-time curve by approximately 40% and 25%, respectively. If the poor metabolizer of MPH proves to be a distinct phenotype, determining the genetic mechanism may be of value for individualizing drug therapy. The more pronounced stimulant effects experienced by women have sex-based abuse liability implications.
(1)乙醇将与消旋甲基苯丙胺(MPH)相互作用,对映选择性地提高血浆中d-MPH水平,并主要产生l-哌醋甲酯作为酯交换代谢物;(2)女性MPH的相对生物利用度低于男性;(3)主观效应存在性别依赖性差异。在一项对10名男性和10名女性进行的随机、正常受试者三交叉研究中,在乙醇给药前30分钟、乙醇(0.6克/千克)给药后30分钟或无乙醇的情况下,口服盐酸消旋MPH(0.3毫克/千克)。比较药代动力学参数。使用视觉模拟量表记录主观效应。一名受试者是新型MPH低代谢者,其数据单独分析。MPH给药后或给药前的乙醇显著(P<0.0001)提高了最大d-MPH血浆浓度(C(max)(±标准差))的几何平均值,分别从15.3(3.37)纳克/毫升提高到21.5(6.81)和21.4(4.86),并将浓度-时间曲线下面积的相应几何平均值从82.9(21.7)纳克·毫升/小时提高到105.2(23.5)和102.9(19.2)。血浆中l-MPH的浓度仅为d-MPH浓度的1%-3%,但在低代谢者中l-MPH超过了d-MPH。代谢物l-哌醋甲酯在血浆中的浓度经常超过1纳克/毫升,而d-哌醋甲酯仅在低皮克/毫升浓度下被检测到。当被问及“你是否感觉到任何药物作用?”时,女性报告的兴奋效应明显大于男性(P<0.05),尽管女性血浆中d-MPH反应-时间曲线下面积的平均值较低。乙醇使血浆d-MPH的C(max)和浓度-时间曲线下面积分别升高约40%和25%。如果MPH低代谢者被证明是一种独特的表型,确定其遗传机制可能对药物治疗个体化有价值。女性经历的更明显的兴奋效应具有基于性别的滥用倾向影响。